The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers

被引：5
|
作者：
Flores-Funes, Diego [1 ,4 ]
Aguilar-Jimenez, Jose [1 ,4 ]
Martinez-Galvez, Maria [2 ,4 ]
Jose Ibanez-Ibanez, Maria [3 ]
Carrasco-Gonzalez, Luis [1 ,4 ]
Ignacio Gil-Izquierdo, Jose [2 ,4 ]
Luis Aguayo-Albasini, Jose [1 ,4 ]
机构：
[1] Hosp Gen Univ JM Morales Meseguer, Serv Cirugia Gen, Murcia, Spain
[2] Hosp Gen Univ JM Morales Meseguer, Serv Radiodiagnost, Murcia, Spain
[3] Hosp Gen Univ JM Morales Meseguer, Med Nucl, Murcia, Spain
[4] Univ Murcia, Fac Med, IMIB Arrixaca, Campus Excelencia Int Mare Nostrum, Murcia, Spain
来源：
CIRUGIA ESPANOLA | 2020年 / 98卷 / 09期
关键词：
Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node biopsy; Targeted axillary dissection; Wire location; Intraoperative ultrasound; Radioioidine seed; Ferromagnetic seed; TUMOR-LOCALIZATION; WIRE LOCALIZATION; CLIPPED NODE; THERAPY; IDENTIFICATION; MARKING; SURGERY; BIOPSY; FEASIBILITY; ACCURACY;
D O I：
10.1016/j.ciresp.2020.03.012
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Targeted axillary dissection (TAD) consists of a new axillary staging technique that combines sentinel lymph node biopsy (SLNB) and clipped lymph node biopsy (CLNB) in the same surgery, in order to re-stage patients with breast cancer and positive axillary lymph nodes undergoing neoadjuvant chemotherapy (NAQT). Prior to the NAQT, the affected lymph node is punctured and a solid marker is left inside echo-guided, in order to biopsy it in the subsequent surgery. There are numerous types of markers: metallic (steel, titanium or polyglycolic acid clips), radioiodine or ferromagnetic seeds, which differ in the method of location (wire, gamma-detection or magnetic probe). The aim of this study is to perform a systematic review about the current status of the TAD, as well as to explain the different techniques and types of axillary marking, based on the current available evidence. (C) 2020 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：510 / 515
页数：6
相关论文
共 50 条
  • [21] Targeted axillary dissection after neoadjuvant chemotherapy
    Steer, Susanne
    Grosse, Regina
    Zentgraf, Holger
    Thomssen, Christoph
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results
    Flores-Funes, Diego
    Aguilar-Jimenez, Jose
    Martinez-Galvez, Maria
    Jose Ibanez-Ibanez, Maria
    Carrasco-Gonzalez, Luis
    Ignacio Gil-Izquierdo, Jose
    Asuncion Chaves-Benito, Maria
    Ayala-De La Pena, Francisco
    Nieto-Olivares, Andres
    Luis Aguayo-Albasini, Jose
    SURGICAL ONCOLOGY-OXFORD, 2019, 30 : 52 - 57
  • [23] AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
    Banys-Paluchowski, M.
    Stickeler, E.
    de Boniface, J.
    Gentilini, O.
    Thill, M.
    Hartmann, S.
    Fasching, P. A.
    Huebner, H.
    Krawczyk, N.
    Blohmer, J-U
    Solbach, C.
    Untch, M.
    Kuehn, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E20 - E21
  • [24] AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
    Banys-Paluchowski, M.
    Stickeler, E.
    de Boniface, J.
    Gentilini, O.
    Thill, M.
    Hartmann, S.
    Fasching, P. A.
    Huebner, H.
    Krawczyk, N.
    Blohmer, J. U.
    Solbach, C.
    Untch, M.
    T, Kuehn
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E93 - E94
  • [25] Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
    Gurleyik, Gunay
    Aksu, Sibel Aydin
    Aker, Fugen
    Tekyol, Kubra Kaytaz
    Tanrikulu, Eda
    Gurleyik, Emin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (06) : 305 - 312
  • [26] Validity of omission of axillary lymph node dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Tsukahara, Daisuke
    Jinno, Hiromitsu
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Sentinel lymph node biopsy as an alternative to axillary lymph node dissection after neoadjuvant chemotherapy
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 73 - 73
  • [28] The role of sentinal lymph node biopsy in determining the need for completion axillary node dissection after neoadjuvant chemotherapy in patients with lymph node positive breast cancer
    Khan, A
    Sabel, M
    Diehl, K
    Schott, A
    Cimmino, V
    Chang, A
    Kleer, C
    Newman, LA
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S102 - S102
  • [29] The role of sentinal lymph node biopsy in determining the need for completion axillary node dissection after neoadjuvant chemotherapy in patients with lymph node positive breast cancer
    A. Khan
    M. Sabel
    K. Diehl
    A. Schott
    V. Cimmino
    A. Chang
    C. Kleer
    L. A. Newman
    Annals of Surgical Oncology, 2004, 11 : S102 - S102
  • [30] Targeted axillary dissection after neoadjuvant therapy in breast cancer
    Ahmed, M.
    Douek, M.
    BRITISH JOURNAL OF SURGERY, 2018, 105 (04) : 313 - 314
12345